applications of biosensors in clinical biochemistry
TRANSCRIPT
APPLICATIONS OF BIOSENSORS IN CLINICAL BIOCHEMISTRY
Dr. Rohini KarunakaranAssociate Professor, Unit of Biochemistry
Preclinical CoordinatorActing Head – Medical Education Unit
Faculty of MedicineAIMST University
Professor Leland C Clark Jnr 1918–2005
8/17/2017 2
FATHER OF THE BIOSENSOR
Invented Clark OxygenElectrode - Pivotal device thatallows real time monitoring ofpatients blood oxygen levels
BIOSENSOR
A biosensor is an analytical device, whichcomprises of a detects, transmit andrecord the information regarding thephysiological, biochemical change or thepresence of a specific analyte (a chemicalor biological substance that needs to bemeasured) by producing a signalproportional to the concentration of thetarget analyte.
8/17/2017 3
Analyte
Biosensor
Bio element Transducer
Electrical Signal
8/17/2017 4
COMPONENTS OF A BIOSENSOR
TARGET ANALYTE
BIORECEPTOR
TRANSDUCER
AMPLIFIER
SIGNAL PROCESSER
RECORDING & DISPLAY
is the specific molecule that is detected by the biosensor
is the biological particle that binds with the target analyte and undergoes conformation
can convert the bioreceptor response from the analyte into a electric, measurable signal.
magnifies the signal manifold from the transducer to make it more noticeable and easier to analyse and interpret.
filters the intensified signal and obtains the proper signal by cancelling noise.
visually represents the data to the ones who analyse and use the information to find solutions to problems.
8/17/2017 7
CHARACTERISTICS OF BIOSENSOR
SENSITIVITY The ability of a biosensor to measure small variations of the concentration of the target analyte
SELECTIVITY
LINEARITY
RESPONSE TIME
PRECISION
ACCURACY
Chemicals Interference must be minimised forobtaining the correct result.
Linearity of the sensor should be high for thedetection of high substrate concentration.
Time necessary for having 95% of the responseThe closeness of agreement between independent measurements on the same sample
The closeness of the agreement between the biosensor measured value (concentration) and the true value the analyte in a test sample
8/17/2017 8
ADVANTAGES
Highly specific
Extremely fast response time
Continuous measurement
Small sample size with minimal preparation required
Portable, Easy-to-use
Cheaper than current technologies
8/17/2017 11
Biosensor & chronic diseases Diabetes mellitus Prevalence of diabetes Nanotechnology Glucose monitoring techniquesNano biosensorFluorescent polymeric nano sensorQuantum dotsNanorobots
Glucose biosensor
8/17/2017 12
CHRONIC DISEASES
Major chronic disease are cancer, asthma,arthritis, diabetes, COPD, hepatitis, HIV/AIDSetc. Nanotechnology is the field that has potentialfor early diagnostic & advancement intreatment of Diabetes mellitus. It is one of the worlds leading health carecrisis.
8/17/2017 13
DIABETES MELLITUSDiabetes mellitus is a disorder that is characterized by change inlevel of blood sugar (glucose) resulting from defects in insulinproduction, insulin action or both.
Around 150 millions are affected from this multifactorialpolygenic disease and number is going to increase in comingfuture.
8/17/2017 15
DIABETES MELLITUS
Goal of diabetes treatment is to control blood glucose level and prevent diabetes complications.Type 1 diabetic must take insulin (oral insulin) to control diabetesType 2 diabetic may be able to control blood glucose by diet adjustment and more exercises
In long term need medication(insulin) to control BGLRequire constant monitoring of glucose level to maintain appropriate glucose levelBlood glucose level in the body are dynamic.
8/17/2017 20
IMMUNOSENSORS
When antibodies are used as a reagent torecognize, bind and detect target analytes
8/17/2017 21
GLUCOWATCH
‘non-invasive’ transcutaneous glucose measurementReverse iontophoresis principle
8/17/2017 22
GLUCOSE MONITORING TECHNIQUES
Nanotechnology had contributed a lot in the field of glucose monitoring and diabetes managementSome of the techniques are:-1) Nano scale biosensors or nano biosensors2) Fluorescent polymeric biosensors or “Smart
tattoo”3) Quantum dots4) Nanorobots
8/17/2017 23
NANOTECHNOLOGY
Nanotechnology
1st sensors are designed using macro-micro scale
components
2nd Nanofabrication technique generate glucose sensors that are nanoscale in
dimension
Small size High surface/volume ratioEnhanced optical propertiesFaster response & improved catalytic activityMore efficient electron transfer from enzyme to electrodeEg:-Nano biosensors based on the property of fluoresence
signals such as FRET-(Forster resonance energy transfer).
NANO BIOSENSOR - ADVANTAGES
It involves biosensing through skin rather than havingelectrode system implanted. In this glucose binding protein (boronic acid derivative)
are incorporated on micro surface layer through layer bylayer assembly of nano film to encapsulate thecomponent.Eg:- Polyethylene glycol The fluorescence property change in response to BGL &
this change can be noted based on optical interrogationthrough skin.
FLUORESCENT POLYMERIC NANOSENSOR OR “SMART TATTOO”
Smart tattoo are implanted into the skin like regular tattoo but need to be replaced on time scale from weeks to months Offer ability for continuous monitoring through skin
with a less invasive approachAdvantages Reduce the need to take blood sample Data collected in a more continuous manner Avoid complication of implanted devices
“SMART TATTOO”
Quantum dots are the colloidal semiconductor nano crystals of a few nanometers in diameter their size& shape controlled during synthesisSynthesized from atom of group II-VI or III-V of periodic
tableSuch as calcium telluride or cadmium selinium forming
nano particles with florescent characteristics
QUANTUM DOTS
AdvantagesAllows rapid optical detection of BGLHave ideal long term implantation (i.e. they will not
photobleach over time)
DisadvantagesFluorescent sensor based on quantum dots will be more
expensive than current electro-chemical sensor. Implantation into body requires stringent toxicity testing.
QUANTUM DOTS
Nanorobot is a tiny machine designed to performspecific task with a precision at nanoscale dimensionsof few nanometers (nm) or less.
It work at atomic, molecular or cellular level toperform task in medical & industrial field
NANOROBOTS
Advantages Has no side effectsOperate freely inside body along blood stream It operates at specific site only
Disadvantages Initial design cost is very highNanorobot design is very complicated
NANOROBOTS
Finger stick Testing
Most common method to monitor blood glucoseProcedure:- Drop of blood is obtained with lancet Blood sample placed on test strip Test strip inserted in glucose meter to display BGLSome diabetics may have to perform
testing four or more times daily
COMMERCIALLY USED GLUCOSE BIOSENSOR
Sub dermal implants
Measures glucose in skin fluids by implanting on skin. Sensors life span 72 hours
Contact lens surface is embedded with sensor & microchip.Measure glucose in tear fluid eye
Smart contact lens
Source-Google contact lens
Source RTS, Medtronic Inc
Based on ultrasonic, electromagnetic & heat capacitySpot measurement on ear clipSensor life span (6 months)
GlucoTrack (Integrity application)
Symphony (echo therapeutics)
Advanced micro abrasion system Enhances the flow of interstitial fluid & molecules across
skin to transdermal surface Sensor life span 24-48 hours
There is a great need to bring synergy among R&Dinstitutions and Government, Industrial houses that leads tosmooth transmission of technology.The level of sophistication, awareness, cost, reliability,
availability and marketing are all factors involved in deciding,whether biosensors would become popular in near future.Promising approach to medical diagnostics by patients or in
doctors officesOther important applications: pathogens, disease
biomarkers, DNA, peroxide, etc.Method of choice for blood glucose in diabeticsRapid diagnostics may lead to more timely and effective
treatment8/17/2017 38
CONCLUSION
A Biosensor is a analytical device convert biological responseto electrical signalDiabetes mellitus is disease occur due to insufficient insulin
production or action or bothNanotechnology provides potential for early diagnosis of
diabetesMain glucose monitoring techniques are Nano biosensor,
“Smart tattoo”, Quantum dots & Nano robots.Commercially used sensors are Accu check , Smart contact
lens, gluco track etc.Progress in this field is rapid but ultimate goal for accurate,
continuous glucose monitoring in patient is yet to be achieved
8/17/2017 39
CONCLUSION
8/17/2017 40
FUTURE CHALLENGES/DIRECTIONS
The most important future challenges for biosensorsconsist of: size, remote operation, reliability,sensitivity, accuracy, sample handling, telemetryand range of analytes
The multidisciplinary arena of expertise necessaryfor the development of biosensors can be sustainedby the collaboration of many areas of academia andindustry. Though the result is a slow process butmost probably the only realistic path to successfulfuture advances in biosensor technology.
Biosensors and their application in healthcare: hot topics - Dilsat Ozkan-Ariksoysal ©2013 Future Science doi:10.4155/EBO.13.347 Future Directions of Biosensors - MdZakir Hossain, Rozina Akter, Anita L Jackson,
Dev S Shrestha. Journal of Nanomedicine Research J Nanomed Res 2016, 3(1):00050Biosensors in clinical biochemistry. P Vadgama. Ann Clin Biochem 1993; 30: 337 340Biosensors for Health, Environment and Biosecurity. www.intechopen.comBiosensors in Applications. Kafashan and Azadshahraki, J Biosens Bioelectron 2016,
7:3Applications of biosensors in the clinical laboratory. A. St John Riv Med Lab - JLM,
Vol. 3, N. 2-S1, 2002Ozkan-Ariksoysal D (2013) Biosensors and their application in healthcare: hot topics.
Biosensors 2-4Wang J (2005) Nanomaterial-based electrochemical biosensors. Analyst 130(4): 421-
426.Mohanty SP, Kougianos E (2006) “Biosensors: A tutorial review”. Potentials IEEE
25(2): 35-40Fan X, White IM, Shopova SI, Zhu H, Suter JD, Sun Y. Sensitive optical biosensors for
unlabeled targets: a review. Anal Chim Acta. 620: 8–26, 2008.Johansson A, Kromer K, Sroka R, Stepp H. Clinical optical diagnostics – Status and
perspectives. Med Laser Appl. 23: 155–174, 2008.8/17/2017 41
REFERENCES